Skip to content
AwardedSpainGoods€1,292,315

SUMINISTRO DE BLINATUMOMAB, MEDICAMENTOS DE DISTRIBUCIÓN EXCLUSIVA DE LA FIRMA "AMGEN.S.A.” CON DESTINO AL SERVICIO DE FARMACIA DEL HOSPITAL UNIVERSITARIO 12 DE OCTUBRE

Published
Published 11 May 2026

Overview

The Madrid Health Service's Hospital Universitario 12 de Octubre procured blinatumomab, an exclusively distributed medicine from Amgen S.A., for its pharmacy service. The contract was awarded to Amgen S.A. on 22 April 2026 for €403,848.48.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€1,292,315
Procedure
Direct
Published
11 May 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€403,848
Award date
22 April 2026
Contract period
— → 17 April 2027
Winner
  • AMGEN. S.A

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    10 May 2026

Contracting authority

  • SERVICIO MADRILEÑO DE SALUD - HOSPITAL UNIVERSITARIO 12 DE OCTUBRE

    Procuring entity

    MADRID, Spain

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: SUMINISTRO DE BLINATUMOMAB, MEDICAMENTOS DE DISTRIBUCIÓN EXCLUSIVA DE LA FIRMA "AMGEN.S.A.” CON DESTINO AL SERVICIO DE FARMACIA DEL HOSPITAL UNIVERSITARIO 12 DE OCTUBRE — won by AMGEN. S.A — Skim